Small Team, Big Impact: How A Biotech Startup Transformed Clinical Trial Supply Management With Korio

For small biotech teams, the stakes of a Phase I/II trial are incredibly high. Relying on manual spreadsheets for global drug logistics isn't just tedious—it’s a risk to patient retention. This case study examines a clinical-stage genetic medicines company that transitioned from manual, Excel-based tracking to a sophisticated Response Technology Services Management (RTSM) solution during a multi-country Phase I/II trial.

The shift wasn't just about upgrading technology; it was about avoiding the "small fish" syndrome, where smaller sponsors are often deprioritized by massive, legacy vendors. The result?

• Zero patients lost due to supply or device issues.

• Seamless tracking of both investigational products and ancillary devices.

• Agile updates that stay ahead of protocol changes.

Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.